Patents by Inventor Marc Deller

Marc Deller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSED BICYCLIC PYRIMIDONES AS WRN INHIBITORS
    Publication number: 20260098041
    Abstract: The present application is concerned with tricyclic pyrimidinones as inhibitors of WRN, as well as pharmaceutical compositions and methods of use related thereto. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: February 26, 2025
    Publication date: April 9, 2026
    Applicant: Incyte Corporation
    Inventors: Le ZHAO, Yanran AI, Marc DELLER, Javier FELICIANO, Ananda GHOSH, Leslie McQUIRTER, Xiaozhao WANG, Eddy YUE, Guofeng ZHANG
  • BICYCLIC COMPOUNDS AS INHIBITORS OF WRN
    Publication number: 20250333419
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: August 30, 2024
    Publication date: October 30, 2025
    Applicant: Incyte Corporation
    Inventors: Joe Barbosa, Yanran Ai, Marc Deller, Balu D. Dherange, Ananda Ghosh, Joe Glenn, JR., Leslie McQuirter, Xiaozhao Wang, Eddy Yue, Guofeng Zhang
  • FUSED BICYCLIC PYRIMIDONES AS WRN INHIBITORS
    Publication number: 20250333420
    Abstract: The present application is concerned with bicyclic pyrimidinones as inhibitors of WRN, as well as pharmaceutical compositions and methods of use related thereto. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: December 13, 2024
    Publication date: October 30, 2025
    Applicant: INCYTE CORPORATION
    Inventors: Stacey SHEPARD, Yanran AI, Joe BARBOSA, Marc DELLER, Ananda GHOSH, Joe Glenn, JR., Leslie McQUIRTER, Lixin SHAO, Xiaozhao WANG, Eddy YUE, Guofeng ZHANG
  • IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES AS WRN INHIBITORS
    Publication number: 20250270218
    Abstract: Disclosed are compounds of Formula (I) and Formula (II), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: November 20, 2024
    Publication date: August 28, 2025
    Applicant: Incyte Corporation
    Inventors: Stacey SHEPARD, Yanran AI, Joe BARBOSA, Marc DELLER, Nikoo FALAHATPISHEH, Ananda GHOSH, Joe Glenn, JR., Leslie McQUIRTER, Yehao QIU, Cooper TAYLOR, Xiaozhao WANG, Eddy YUE, Guofeng ZHANG
  • IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES HAVING A COVALENT WARHEAD AT THE 3-POSITION AS WRN INHIBITORS
    Publication number: 20250270217
    Abstract: Disclosed are compounds of Formula (I) and Formula (II), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: November 20, 2024
    Publication date: August 28, 2025
    Applicant: Incyte Corporation
    Inventors: Yanran AI, Joe BARBOSA, Huan CHEN, Marc DELLER, Balu D. DHERANGE, Nikoo FALAHATPISHEH, Ananda GHOSH, Joe Glenn, JR., Yong LI, Leslie McQUIRTER, Yehao QIU, Stacey SHEPARD, Cooper TAYLOR, Xiaozhao WANG, Eddy Yue, Guofeng ZHANG, Le ZHAO, Zhitong ZHENG
  • BICYCLIC COMPOUNDS AS INHIBITORS OF WRN
    Publication number: 20250236622
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing, or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: August 30, 2024
    Publication date: July 24, 2025
    Applicant: Incyte Corporation
    Inventors: Yanran Ai, Joe Barbosa, Marc Deller, Balu D. Dherange, Ananda Ghosh, Joe Glenn, JR., Leslie McQuirter, Xiaozhao Wang, Eddy Yue, Guofeng Zhang